Antibodies that Inhibit Malaria Merozoite Surface Protein–1 Processing and Erythrocyte Invasion Are Blocked by Naturally Acquired Human Antibodies

Merozoite surface protein–1 (MSP-1) of the human malaria parasite Plasmodium falciparum undergoes at least two endoproteolytic cleavage events during merozoite maturation and release, and erythrocyte invasion. We have previously demonstrated that mAbs which inhibit erythrocyte invasion and are specific for epitopes within a membrane-proximal, COOH-terminal domain of MSP-1 (MSP-119) prevent the critical secondary processing step which occurs on the surface of the extracellular merozoite at around the time of erythrocyte invasion. Certain other anti–MSP-119 mAbs, which themselves inhibit neither erythrocyte invasion nor MSP-1 secondary processing, block the processing-inhibitory activity of the first group of antibodies and are termed blocking antibodies. We have now directly quantitated antibody-mediated inhibition of MSP-1 secondary processing and invasion, and the effects on this of blocking antibodies. We show that blocking antibodies function by competing with the binding of processing-inhibitory antibodies to their epitopes on the merozoite. Polyclonal rabbit antibodies specific for certain MSP-1 sequences outside of MSP-119 also act as blocking antibodies. Most significantly, affinity-purified, naturally acquired human antibodies specific for epitopes within the NH2-terminal 83-kD domain of MSP-1 very effectively block the processing-inhibitory activity of the anti-MSP-119 mAb 12.8. The presence of these blocking antibodies also completely abrogates the inhibitory effect of mAb 12.8 on erythrocyte invasion by the parasite in vitro. Blocking antibodies therefore (a) are part of the human response to malarial infection; (b) can be induced by MSP-1 structures unrelated to the MSP-119 target of processing-inhibitory antibodies; and (c) have the potential to abolish protection mediated by anti–MSP-119 antibodies. Our results suggest that an effective MSP-119–based falciparum malaria vaccine should aim to induce an antibody response that prevents MSP-1 processing on the merozoite surface.

[1]  D. Kaslow,et al.  The need for assays predictive of protection in development of malaria bloodstage vaccines. , 1997, Parasitology today.

[2]  A. Holder,et al.  A 22 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex. , 1996, Molecular and biochemical parasitology.

[3]  J. Berzofsky,et al.  Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. , 1996, Journal of immunology.

[4]  M. Blackman,et al.  Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1. , 1996, Experimental parasitology.

[5]  A. Holder,et al.  Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. , 1996, The Journal of infectious diseases.

[6]  P. Barr,et al.  A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria , 1996, Infection and immunity.

[7]  P. McKean,et al.  Processing of the Plasmodium chabaudi chabaudi AS merozoite surface protein 1 in vivo and in vitro. , 1995, Molecular and biochemical parasitology.

[8]  D. Kaslow,et al.  Immunogenicity and In Vivo Efficacy of Recombinant Plasmodium falciparum Merozoite Surface Protein-1 in Aotus Monkeys , 1995, Molecular medicine.

[9]  A. Holder,et al.  Naturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro , 1994, Infection and immunity.

[10]  A. Holder,et al.  Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein , 1994, The Journal of experimental medicine.

[11]  M. Grainger,et al.  N-terminal amino acid sequence of the Plasmodium falciparum merozoite surface protein-1 polypeptides. , 1994, Molecular and biochemical parasitology.

[12]  A. Holder.  Proteins on the surface of the malaria parasite and cell invasion , 1994, Parasitology.

[13]  A. Holder,et al.  Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. , 1994, Molecular and biochemical parasitology.

[14]  A. Holder,et al.  Immunization against malaria with a recombinant protein , 1994, Parasite immunology.

[15]  P. McKean,et al.  A single amino acid determines the specificity of a monoclonal antibody which inhibits Plasmodium chabaudi AS in vivo. , 1993, Molecular and biochemical parasitology.

[16]  A. Holder,et al.  A conserved parasite serine protease processes the Plasmodium falciparum merozoite surface protein-1. , 1993, Molecular and biochemical parasitology.

[17]  A. Holder,et al.  Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1. , 1993, Molecular and biochemical parasitology.

[18]  T. Daly,et al.  A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice , 1993, Infection and immunity.

[19]  T. McCutchan,et al.  Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). , 1993, Molecular and biochemical parasitology.

[20]  A. Holder,et al.  Use of a recombinant baculovirus product to measure naturally-acquired human antibodies to disulphide-constrained epitopes on the P. falciparum merozoite surface protein-1 (MSP1). , 1993, FEMS immunology and medical microbiology.

[21]  P. Barr,et al.  A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. , 1992, Journal of immunology.

[22]  A. Holder,et al.  Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (Pf MSP1) of Plasmodium falciparum are associated with reduced malaria morbidity , 1992, Parasite immunology.

[23]  L. Cooper,et al.  Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1. , 1992, Molecular and biochemical parasitology.

[24]  A. Holder,et al.  Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1. , 1992, Molecular and biochemical parasitology.

[25]  A. Holder,et al.  Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. , 1991, Molecular and biochemical parasitology.

[26]  H. Whittle,et al.  Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. , 1991, Molecular and biochemical parasitology.

[27]  A. Sabchareon,et al.  Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes , 1990, The Journal of experimental medicine.

[28]  Simpson Aj,et al.  A simple method for the recovery of purified recombinant peptides cleaved from glutathione-S-transferase-fusion proteins. , 1990 .

[29]  A. Holder,et al.  A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion- inhibiting antibodies , 1990, The Journal of experimental medicine.

[30]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[31]  G. Hui,et al.  Serum from Pf195 protected Aotus monkeys inhibit Plasmodium falciparum growth in vitro. , 1987, Experimental parasitology.

[32]  J. McBride,et al.  Topography of epitopes on a polymorphic schizont antigen of Plasmodium falciparum determined by the binding of monoclonal antibodies in a two‐site radioimmunoassay , 1987, Parasite immunology.

[33]  K. Tanabe,et al.  Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. , 1987, Journal of molecular biology.

[34]  A. Holder,et al.  Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum , 1987, Parasitology.

[35]  J. McBride,et al.  Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. , 1987, Molecular and biochemical parasitology.

[36]  M. Perkins,et al.  Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites. , 1985, Journal of immunology.

[37]  T. Daly,et al.  Passive immunization against murine malaria with an IgG3 monoclonal antibody. , 1984, Journal of immunology.

[38]  A. Holder,et al.  Immunization against blood-stage rodent malaria using purified parasite antigens , 1981, Nature.

[39]  P. Fraker,et al.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.

[40]  W. Whitehouse,et al.  Invasion of erythrocytes by malaria merozoites. , 1975, Science.

[41]  P. Cuatrecasas,et al.  The purification of beta-galactosidase from Escherichia coli by affinity chromatography. , 1971, The Journal of biological chemistry.

[42]  Bradley Rd.  VARIETIES OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE. , 1964 .

[43]  I. McGregor,et al.  Treatment of East African P. falciparum malaria with West African human γ-globulin , 1963 .

[44]  H. Gilles,et al.  ADULT AND CORD-BLOOD GAMMA-GLOBULIN AND IMMUNITY TO MALARIA IN NIGERIANS , 1962 .

[45]  I. McGregor,et al.  Gamma-Globulin and Acquired Immunity to Human Malaria , 1961, Nature.

[46]  M. Blackman,et al.  Purification of Plasmodium falciparum merozoites for analysis of the processing of merozoite surface protein-1. , 1994, Methods in cell biology.

[47]  A. Holder,et al.  What is the function of MSP-I on the malaria merozoite? , 1994, Parasitology today.

[48]  M. Galinski,et al.  The adhesion of malaria merozoite proteins to erythrocytes: a reflection of function? , 1991, Research in immunology.

[49]  F. Abath,et al.  A simple method for the recovery of purified recombinant peptides cleaved from glutathione-S-transferase-fusion proteins. , 1990, Peptide research.

[50]  M. Ashburner.  A Laboratory manual , 1989 .